Literature DB >> 2999002

Epidemic of LAV/HTLV III infection in drug addicts in Milan: serological survey and clinical follow-up.

A Lazzarin, M Galli, D Geroldi, A Zanetti, P Crocchiolo, F Aiuti, M Moroni.   

Abstract

A clinico-epidemiological study is reported concerning a group of 306 parenteral drug addicts (PDAs), 71 of whom were affected with the lymphadenopathy syndrome (LAS); all were followed-up between 1981 and 1984. Although full-blown acquired immune deficiency syndrome (AIDS) was observed only in one case, none of the other patients examined have undergone complete recovery so far. The results of our study point to a wide circulation of LAV/HTLV III among our group of PDAs, starting at least as early as 1981 and preceding by a few months the development of clinical signs and symptoms of LAS. A peak incidence of the latter was observed during the winter of 1983/1984, running parallel with a marked increase in seropositives for LAV/HTLV III antibody. Drug addiction, sexual promiscuity and a low standard of living all seem to play a decisive role in the spread of the infection and, consequently, of the diseases related to it (LAS, AIDS-related complex and AIDS). In fact, PDAs appear to represent the major source of the disease in Italy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999002     DOI: 10.1007/bf01667214

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  UK case of AIDS in an intravenous drug abuser.

Authors:  S J Winterton; J B Warren; P J Barnes
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

2.  Persistent, generalized lymphadenopathy among homosexual males.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1982-05-21       Impact factor: 17.586

3.  Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.

Authors:  F Brun-Vezinet; C Rouzioux; F Barre-Sinoussi; D Klatzmann; A G Saimot; W Rozenbaum; D Christol; J C Gluckmann; L Montagnier; J C Chermann
Journal:  Lancet       Date:  1984-06-09       Impact factor: 79.321

4.  Outbreak of persistent, unexplained, generalized lymphadenopathy with immunological abnormalities in drug addicts in Milan.

Authors:  A Lazzarin; M Galli; M Introna; C Negri; A Mantovani; L Mella; P Ferrante; C Parravicini; M Trombini; F Aiuti
Journal:  Infection       Date:  1984 Nov-Dec       Impact factor: 3.553

5.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

6.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

7.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

  7 in total
  2 in total

1.  Sustained AIDS education campaigns and behavioural changes in Italian drug abusers.

Authors:  F Bortolotti; A Stivanello; F Noventa; G Forza; N Pavanello; A Bertolini
Journal:  Eur J Epidemiol       Date:  1992-03       Impact factor: 8.082

2.  HIV infection in intravenous drug abusers in Berlin: risk factors and time trends.

Authors:  K Stark; R Müller; I Guggenmoos-Holzmann; S Deininger; E Meyer; U Bienzle
Journal:  Klin Wochenschr       Date:  1990-04-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.